Linus Pauling Institute

Netke S, Niedzwiecki A.  1995.  Liver ascorbate and glutathione disulfide levels in guinea pigs are affected by dietary ascorbate intake and the type of diet.. Int J Vitam Nutr Res. 65(3):187-92.

Nemanic S, Hollars K, Nelson NC, Bobe G.  2015.  COMBINATION OF COMPUTED TOMOGRAPHIC IMAGING CHARACTERISTICS OF MEDIAL RETROPHARYNGEAL LYMPH NODES AND NASAL PASSAGES AIDS DISCRIMINATION BETWEEN RHINITIS AND NEOPLASIA IN CATS.. Vet Radiol Ultrasound. 56(6):617-27.

Nakamura Y, Kulkarni NN, Takahashi T, Alimohamadi H, Dokoshi T, Liu E, Shia M, Numata T, Luo EWc, Gombart AF et al..  2024.  Increased LL37 in psoriasis and other inflammatory disorders promotes LDL uptake and atherosclerosis.. J Clin Invest. 134(5)

Myzak MC, Ho E, Dashwood RH.  2006.  Dietary agents as histone deacetylase inhibitors.. Mol Carcinog. 45(6):443-6.

Myzak MC, Carr AC.  2002.  Myeloperoxidase-dependent caspase-3 activation and apoptosis in HL-60 cells: protection by the antioxidants ascorbate and (dihydro)lipoic acid.. Redox Rep. 7(1):47-53.

Myzak MC, Hardin K, Wang R, Dashwood RH, Ho E.  2006.  Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells.. Carcinogenesis. 27(4):811-9.

Myzak MC, P Karplus A, Chung F-L, Dashwood RH.  2004.  A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase.. Cancer Res. 64(16):5767-74.

Myzak MC, Dashwood RH.  2006.  Chemoprotection by sulforaphane: keep one eye beyond Keap1.. Cancer Lett. 233(2):208-18.

Myzak MC, Tong P, Dashwood W-M, Dashwood RH, Ho E.  2007.  Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects.. Exp Biol Med (Maywood). 232(2):227-34.

Myzak MC, W Dashwood M, Orner GA, Ho E, Dashwood RH.  2006.  Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice.. FASEB J. 20(3):506-8.

Myzak MC, Dashwood RH.  2006.  Histone deacetylases as targets for dietary cancer preventive agents: lessons learned with butyrate, diallyl disulfide, and sulforaphane.. Curr Drug Targets. 7(4):443-52.

Mustacich DJ, Bruno RS, Traber MG.  2007.  Vitamin E.. Vitam Horm. 76:1-21.

Mustacich DJ, Vo AT, Elias VD, Payne K, Sullivan L, Leonard SW, Traber MG.  2007.  Regulatory mechanisms to control tissue alpha-tocopherol.. Free Radic Biol Med. 43(4):610-8.

Mustacich DJ, Leonard SW, Patel NK, Traber MG.  2010.  Alpha-tocopherol beta-oxidation localized to rat liver mitochondria.. Free Radic Biol Med. 48(1):73-81.

Mustacich DJ, Leonard SW, Devereaux MW, Sokol RJ, Traber MG.  2006.  Alpha-tocopherol regulation of hepatic cytochrome P450s and ABC transporters in rats.. Free Radic Biol Med. 41(7):1069-78.

Mukherjee S, Kapp EA, Lothian A, Roberts AM, Vasil'ev YV, Boughton BA, Barnham KJ, W Kok M, Hutton CA, Masters CL et al..  2017.  Characterization and Identification of Dityrosine Cross-Linked Peptides Using Tandem Mass Spectrometry.. Anal Chem. 89(11):6136-6145.

Muchiri RN, Kibitel J, Redick MA, van Breemen RB.  2022.  Advances in Magnetic Microbead Affinity Selection Screening: Discovery of Natural Ligands to the SARS-CoV-2 Spike Protein.. J Am Soc Mass Spectrom. 33(1):181-188.

Muchiri RN, Kowal KE, Hensley K, Feinstein DL, van Breemen RB.  2018.  Analysis of lanthionine ketimine ethyl ester in mouse serum, whole blood and tissues using ultrahigh-pressure liquid chromatography/tandem mass spectrometry.. Rapid Commun Mass Spectrom. 32(22):1941-1948.

Muchiri RN, van Breemen RB.  2020.  Affinity selection-mass spectrometry for the discovery of pharmacologically active compounds from combinatorial libraries and natural products.. J Mass Spectrom. :e4647.

Muchiri RN, van Breemen RB.  2021.  Drug discovery from natural products using affinity selection-mass spectrometry.. Drug Discov Today Technol. 40:59-63.

Muchiri RN, van Breemen RB.  2020.  Single Laboratory Validation of UHPLC-MS/MS Assays for Six Milk Thistle Flavonolignans in Human Serum.. J AOAC Int.

Morgan E, Gamble JT, Pearce MC, Elson DJ, Tanguay RL, Kolluri SKumar, Reich NO.  2019.  Improved in vivo targeting of BCL-2 phenotypic conversion through hollow gold nanoshell delivery.. Apoptosis.

Moreau R, Nguyen BT, Doneanu CE, Hagen TM.  2005.  Reversal by aminoguanidine of the age-related increase in glycoxidation and lipoxidation in the cardiovascular system of Fischer 344 rats.. Biochem Pharmacol. 69(1):29-40.

Moreau R, Heath S-HD, Doneanu CE, Harris RA, Hagen TM.  2004.  Age-related compensatory activation of pyruvate dehydrogenase complex in rat heart.. Biochem Biophys Res Commun. 325(1):48-58.

Moreau R, Heath S-HD, Doneanu CE, J Lindsay G, Hagen TM.  2003.  Age-related increase in 4-hydroxynonenal adduction to rat heart alpha-ketoglutarate dehydrogenase does not cause loss of its catalytic activity.. Antioxid Redox Signal. 5(5):517-27.